ModivCare Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

false 0001220754 0001220754 2024-12-13 2024-12-13

 

 

 

 

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

 

 

 

Registrant’s telephone number, including area code: (303) 728-7012

 

N/A

 

Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

On December 13, 2024, Christopher S. Shackelton and Rahul Samant resigned from the Board of Directors (the “Board”) of ModivCare Inc. (the “Company”), effective as of December 13, 2024. Their resignations are not a result of any disagreement with the Company. The Board has appointed Leslie V. Norwalk as Interim Chair of the Board, effective as of December 13, 2024.

 

 

(d) Exhibits.

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.